Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease

Mary E Reyland1, David N M Jones2

  • 1Department of Craniofacial Biology, School of Dental Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Insights

Protein kinase C-delta (PKCδ) has dual roles in cell death and proliferation. Inhibiting PKCδ may reduce chemotherapy toxicity, but it also promotes tumor growth in some cancers.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Protein kinase C-delta (PKCδ) is a serine-threonine kinase with a newly recognized dual role in regulating cell death and proliferation.
  • Studies in knockout mice reveal PKCδ's pro-apoptotic function in response to DNA damage and its role as a tumor promoter in certain cancers.
  • PKCδ acts upstream of apoptotic pathways, as inhibiting it suppresses cytochrome c release and caspase activation in non-transformed cells.

Purpose of the Study:

  • To review the current understanding of PKCδ's biological functions.
  • To explore the prospects of targeting PKCδ for therapeutic interventions in human diseases.
  • To elucidate the regulatory mechanisms underlying PKCδ's distinct roles in cell death and proliferation.

Main Methods:

  • Review of existing literature and studies involving PKCδ knockout mice.
  • Analysis of data on PKCδ expression in human breast cancer subtypes.
  • Examination of cellular assays investigating apoptotic pathway regulation.

Main Results:

  • PKCδ deficiency protects against DNA damage-induced and physiological apoptosis.
  • PKCδ inhibition reduces irradiation and chemotherapy-induced toxicity.
  • PKCδ acts as a tumor promoter in mouse models of mammary gland and lung cancer.
  • Elevated PKCδ expression correlates with poor prognosis in Her2+ and other breast cancer subtypes.

Conclusions:

  • PKCδ exhibits opposing roles, acting as a pro-apoptotic factor and a tumor promoter.
  • Targeting PKCδ presents a therapeutic opportunity for managing treatment toxicity.
  • Further research into PKCδ regulation is crucial for developing effective cancer therapies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.6K